Antibody / Antigen for Intestine Detection -HP/RV/EV71/FOB
Intestinal diseases pose a growing global public health threat. According to the World Health Organization (WHO), approximately 1.7 billion people are infected with enterovirus annually, with rotavirus alone claiming the lives of over 215,000 children under the age of five each year.
✨Trusted by leading partners worldwide, Cnpair is committed to developing high-performance antibody pairs and antigens for intestinal
diseases, driving innovation in IVD.
Helicobacter Pylori
⦁ Natural antigens with broad epitope coverage
⦁ High coincidence with the Urea Breath Test
⦁ Compatible with multiple testingplatforms
Rotavirus
⦁ World-class performance
⦁ High sensitivity
⦁ No cross-reactivity with common diarrheal pathogens
Enterovirus 71
⦁ High accuracy
⦁ Multi-platform compatibility
⦁ No cross-reactivity with Coxsackievirus A16 (CA16)
Fecal Occult Blood
⦁ Assist in early colorectal cancer screening
⦁ Excellent performance on LF
⦁ Strong anti-interference capability
Why choose cnpair ?
1. PowerfulInnovations
Cnpair is deeply invested in R&D, holding over 50 patents. Ourinnovations have been successfully translated into a wide rangeof core diagnostic products.
2. Integrated Solutions: Product plus Service
We provide full-cycle technical support-from raw materialdevelopment to fully customized diagnostic solutions
3. Quality Assurance
Cnpair is certified under IS0 13485 &lS0 9001,and committedto delivering high-quality,reliable products and services tocustomers.
4. Accessable & Affordable
Cnpair maintains astrong focus onin-house R&D andproduction, actively shielding from tariff fluctuations whilesecuring a stable product supply.
